Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 and Older With Asthma

Study Title
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromaxֲ® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Teva Identifier
ABS-AS-301
ClinicalTrials.gov Identifier
NCT01424813
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
12 Years and older
Trial Duration
12/01/2012 - 11/01/2013
Phase
Phase 3

Study Type

Interventional